Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · IEX Real-Time Price · USD
8.48
-0.17 (-1.91%)
Jul 22, 2024, 10:10 AM EDT - Market open

MRVI Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018
Net Income
-131.04-119.03220.21182.0488.97-4.47
Upgrade
Depreciation & Amortization
51.6348.7838.133.5425.8424.08
Upgrade
Share-Based Compensation
40.6634.5918.6710.4624.631.68
Upgrade
Other Operating Activities
71.44161.88259142.5312.752.82
Upgrade
Operating Cash Flow
32.68126.22535.98368.57152.1924.12
Upgrade
Operating Cash Flow Growth
-92.88%-76.45%45.42%142.18%531.09%-
Upgrade
Capital Expenditures
-56.93-52.69-29.26-14.39.09-17.15
Upgrade
Acquisitions
0.11-69.62-238.35119.96-3.020
Upgrade
Investing Cash Flow
-56.82-122.31-267.61105.666.07-17.15
Upgrade
Share Issuance / Repurchase
0000292.13-0.23
Upgrade
Debt Issued / Paid
-5.92-5.77-5.44-6187.63-2.64
Upgrade
Other Financing Activities
-36.52-55.32-182.06-153.05-426.55-1.3
Upgrade
Financing Cash Flow
-42.44-61.09-187.5-159.0553.21-4.17
Upgrade
Exchange Rate Effect
000-0.090.020.03
Upgrade
Net Cash Flow
-66.58-57.1880.87315.09211.482.83
Upgrade
Free Cash Flow
-24.2573.54506.71354.27161.286.97
Upgrade
Free Cash Flow Growth
--85.49%43.03%119.66%2214.90%-
Upgrade
Free Cash Flow Margin
-8.85%25.45%57.39%44.33%56.77%4.87%
Upgrade
Free Cash Flow Per Share
-0.180.563.853.0915.580.03
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).